Posted by 
Type 2 diabetes is currently controlled by insulin injections, healthy diet, regular exercise and monitoring blood glucose levels.
Two studies by the University of Adelaide have demonstrated for the first time how potential new anti-diabetic drugs could target the body at the molecular level to treat the condition.
Currently the most commonly prescribed anti-diabetic drug is Metformin, which acts on the liver to reduce glucose production.
However, these new drugs work completely differently by targeting a protein receptor known as PPARgamma found in fat tissue throughout the body, and then either fully or partially activating it to lower blood sugar.
It does this by increasing insulin and changing the metabolism of fat and sugar. This make it efficient at reducing blood sugar.
